Mitek_Sports_Medicine_Introduces_Comprehensive-4f951d673a40a9e48269bfd4e105c577.jpg

Mitek Sports Medicine Introduces Comprehensive Knee Arthroscopy Platform for ACL and Meniscal Repair

Posted On March 17, 2017 By OrthoSpineNews In Sports Medicine /  

SAN DIEGO, March 16, 2017 /PRNewswire/ — DePuy Synthes Mitek Sports Medicine* has launched a new suite of knee arthroscopy solutions to help improve operating room efficiency, simplify ACL and meniscus repair, and make these surgeries more reproducible. The new platform expands the company’s leadership in products and instruments for knee arthroscopy by combining performance with an easy-to-use solution for every step of the procedure. The announcement was made here at the American Academy of Orthopaedic Surgeons Annual Meeting.

Meniscus and ACL surgery are two of the most common knee procedures performed worldwide. In 2016 580,000 meniscal repairs and more than 865,000 ACL surgeries were projected to be performed worldwide.1 With such a high-volume of surgeries, creating efficiency in the operating room through simple, versatile instruments and implants is critical for surgeons.

The new suite of products from Mitek Sports Medicine is designed to promote operating room efficiency and simplicity from the start to finish of the procedure, together with implants that may help promote stability:

  • The SPEEDTRAP™ Graft Prep System allows the surgeon to easily and quickly whipstitch, or suture, one tendon end without using a needle in about 20 seconds, which is at least 77 percent faster2 than traditional techniques and offers strong tension.
  • The TRUESPANTM Meniscal Repair System streamlines arthroscopic meniscal repair by offering a unique delivery system with an ergonomic handle, single trigger, and auto-reloading mechanism for quick, simple one-handed use. The TRUESPAN System also features the only 24-degree curved needle option on the market, which may provide better access to challenging tear locations.
  • The TWISTR™ Retrograde Reamer is used to drill the tunnels for graft placement during ACL reconstruction. The TWISTR Reamer can be set to drill 13 different tunnel diameters making it the only one-size-fits-all device of its kind on the market. The adjustable design simplifies inventory management by eliminating the need to stock multiple reamer sizes and help reduce cost during cases where more than one size reamer is needed. This product will be commercially available in the US in Q3 2017.
  • The RIGIDLOOP® Adjustable Cortical System, a titanium cortical button and adjustable loop implant, holds the graft in place in the femoral tunnel. The innovative design with adjustable loops eliminates need for multiple size implants. Simple one-handed tensioning technique allows surgeons to advance graft to completely fill the socket with stronger fixation and less graft displacement compared to similar adjustable loop devices.
  • The INTRAFIX® ADVANCE Tibial Fastener System provides rigid fixation of the graft in the tibial tunnel. The sheath and screw implant duo is designed to protect soft tissue grafts and promote integration with the surrounding bone to achieve a strong and stable fixation.

“The new products added to the Mitek Sports Medicine knee platform are well designed,” said Amir R. Moinfar, MD, orthopaedic surgeon at Elite Orthopaedic and Musculoskeletal Center in Glen Burnie, Md. “Either used individually or in concert with one another, their numerous features afford the opportunity to perform ACL reconstruction and meniscus repair safely, reproducibly and efficiently, ultimately assisting me in helping my patients.”

Matt Jewett, Platform Leader, Mitek Sports Medicine said, “We recognize that our customers need solutions for knee arthroscopy that deliver performance, reproducibility and operating room efficiency. We are very excited to be bringing these innovative knee products to our customers to address these needs at every step and help them treat patients with ACL and meniscal injuries.”

About DePuy Synthes Companies
DePuy Synthes Companies, part of the Johnson & Johnson Family of Companies, provides one of the most comprehensive orthopaedics portfolios in the world. DePuy Synthes Companies solutions, in specialties including joint reconstruction, trauma, craniomaxillofacial, spinal surgery and sports medicine, are designed to advance patient care while delivering clinical and economic value to health care systems worldwide. For more information, visit www.depuysynthes.com.

*DePuy Synthes represents the products and services of DePuy Synthes, Inc. and its subsidiaries.
DSUS/MTK/0317/0939 03/17

1 Millennium Research Group Sports Medicine Device Market 2015 Analyses:  US, EMEA, ASPAC and LATAM Markets, September 2016.
2 DePuy Synthes Mitek Sports Medicine, Raynham, MA. Document 103304691 2016.

SOURCE DePuy Synthes

Related Links

http://www.depuysynthes.com

Read More
Rotation_CollagenImplant_WEB.png

Rotation Medical Bioinductive Implant Induces New Tissue Formation in Patients with Large and Massive Rotator Cuff Tears

Posted On March 15, 2017 By OrthoSpineNews In Sports Medicine /  

March 15, 2017

SAN DIEGO–(BUSINESS WIRE)–Rotation Medical Inc., a medical device company focused on developing new technologies to treat rotator cuff disease, today announced results of the first study of the company’s collagen-based Bioinductive Implant on patients with large and massive rotator cuff tears. The results, which were presented at the American Academy of Orthopaedic Surgeons (AAOS) in San Diego, showed the Bioinductive Implant induced new tissue formation in all study participants.

“Failure of large and revision rotator cuff repairs continues to be a challenging problem,” said Felix H. “Buddy” Savoie, MD, study investigator and chairman of the Department of Orthopedics at Tulane University School of Medicine in New Orleans. “This study is exciting for the field of rotator cuff repair, as it showed that the Bioinductive Implant induces new tissue formation and assists in healing for patients with large and massive rotator cuff tears.”

The study enrolled 23 patients – 11 with large (two tendon) and 12 with massive (three tendon) rotator cuff tears – 16 of whom had previous rotator cuff repairs. All patients received the Rotation Medical Bioinductive Implant via arthroscopic surgery. New tissue formation was observed in all 23 patients, and 22 successfully healed their rotator cuffs. Postoperative ultrasound was used to assess tendon thickness at three, six and 12 months, and MRIs were taken at six and 12 months to confirm healing and tendon thickness. Rotator cuff thickness ranged from 5-9 mm at most recent follow-up, and all clinical scores improved significantly over time.

“Results of this study are consistent with the biopsy study published last month in Arthroscopy showing that our Bioinductive Implant promotes the growth of tendon-like tissue,” said Martha Shadan, president and CEO of Rotation Medical. “There is a growing body of evidence demonstrating that the Rotation Medical Rotator cuff system has the potential to transform the treatment of rotator cuff disease by addressing both the biomechanics and biology required to heal a rotator cuff tendon tear.”

The study, “Preliminary Investigation of a Bio-Inductive Collagen Patch used on Large/Massive Rotator Cuff Tears,” adds to the growing body of literature supporting the use of the Bioinductive Implant as a novel and effective treatment for rotator cuff tears. Additional publications and information about the Rotation Medical rotator cuff system are available on the company’s website.

For important safety information, visit http://rotationmedical.com/our-solution/risks/.

Rotation Medical is also exhibiting at the meeting in Booth #5916.

About Rotator Cuff Tears

Rotator cuff damage is the most common source of shoulder pain, affecting more than 4 million people annually in the U.S. Traditional approaches to treating degenerate or torn rotator cuffs often do not address the poor quality of the underlying tendon tissue, and a significant number of these tendons, after standard treatment, either degenerate further and/or re-tear.

About the Rotation Medical Bioinductive Implant

Cleared by the U.S. Food and Drug Administration in March 2014, the Rotation Medical Bioinductive Implant is designed to address this limitation by inducing new tissue growth at the site of implantation, resulting in increased tendon thickness and healing of tendon defects with new tissue growth. The collagen-based implant is about the size of a postage stamp and it is part of the Rotation Medical rotator cuff system, which also includes disposable instruments that allow the arthroscopic procedure to be performed easily and quickly.

About Rotation Medical

Rotation Medical Inc. was founded in 2009 and is committed to improving the treatment of rotator cuff disease with the Rotation Medical rotator cuff system, a breakthrough technology that has the potential to prevent rotator cuff disease progression and reduce re-tears by inducing the growth of new tendinous tissue. The company is privately held and funded by New Enterprise Associates (NEA), Life Sciences Partners (LSP) and Pappas Ventures. For more information, visit www.rotationmedical.com.

Contacts

Merryman Communications
Joni Ramirez, 323-532-0746
joni@merrymancommunications.com

Read More
image-20150520-11431-12g7rlx.jpg

High rate of return to running following arthroscopic hip surgery

Posted On March 14, 2017 By OrthoSpineNews In Sports Medicine /  

SAN DIEGO, March 14, 2017 /PRNewswire-USNewswire/ — Ninety-six percent of patients who were recreational or competitive runners prior to developing hip bone spurs returned to their sport within nine months of arthroscopic surgery, according to research presented today at the 2017 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).

Bones spurs on the hip joint, or femoracetabular impingement (FAI), is a common condition in which there is extra growth along the bones, giving the bones an irregular shape and causing them to rub together during movement. Over time, the friction can damage the soft tissue surrounding the hip joint causing pain or a limp, which limits activity. Arthroscopic hip surgery is a minimally invasive procedure during which a small camera, called an arthroscope, is inserted into the hip joint guiding the surgeon to remove the bone growths.

In the study, researchers retrospectively reviewed the records of 51 FAI patients (23 men and 28 women) who had undergone hip arthroscopy and identified themselves as recreational or competitive runners. Patient outcomes two years after arthroscopy were assessed using a running-specific questionnaire and common outcome and activity measurements.

The average age of patients was 27 years, and body mass index (BMI) was 24 kg/m2 (a patient with a BMI greater than 25 is considered overweight). Prior to surgery, patients had stopped running because of FAI pain for an average of 9 months.

Among the results:

  • After surgery, 49 patients (96 percent) returned to running at an average of 9 months after surgery.
  • Increasing BMI was associated with a slower return to running.
  • Patients who had stopped running for greater than eight months prior to hip arthroscopy returned to running significantly more slowly than those who had stopped running closer to surgery.
  • After two years, the mean running distance of patients had decreased significantly from an average of 10 miles per week to 6 miles.
  • Patient outcome and activity scores all improved significantly for patients after surgery, with females showing greater progress than males.

“Arthroscopy is a minimally invasive and effective treatment for FAI in runners,” said David M. Levy, MD, lead author of the study and an orthopaedic surgeon at Rush University Medical Center in Chicago.

“High Rate of Return to Running” appeared online Sept. 12, 2016 in the American Journal of Sports Medicine.

Study abstract

2017 AAOS Annual Meeting Disclosure Statements

The American Academy of Orthopaedic Surgeons
With more than 39,000 members, the American Academy of Orthopaedic Surgeons (AAOS) is the world’s largest association of musculoskeletal specialists. The AAOS provides education programs for orthopaedic surgeons and allied health professionals, champions and advances the highest musculoskeletal care for patients, and is the authoritative source of information on bone and joint conditions, treatments, and related issues.

Visit AAOS at:
Newsroom.aaos.org for bone and joint health news, stats, facts, images and interview requests.
ANationinMotion.org for inspirational patient stories, and orthopaedic surgeon tips on maintaining bone and joint health, avoiding injuries, treating musculoskeletal conditions and navigating recovery.
Orthoinfo.org for patient information on hundreds of orthopaedic diseases and conditions.
Facebook.com/AAOS1
Twitter.com/AAOS1

CONTACT: Sheryl Cash, 847-384-4032, 847-804-7486, scash@aaos.org, or Lauren Pearson Riley, 847-384-4031, 708-227-1773, pearson@aaos.org

This information is being sent to you by:
American Academy of Orthopaedic Surgeons
9400 W. Higgins Road, Rosemont, IL , 60018,
http://www.aaos.org

Read More
161011-Oska-Pulse.jpg

The Hazards of Travel and How to Minimize Your Risk

Posted On March 13, 2017 By OrthoSpineNews In Spine, Sports Medicine /  

Greg Houlgate, Contributor – CEO/President Oska Wellness, Inc.

 

As a child, I couldn’t wait to go to the airport to watch the enormous planes roll up to the gate and witness the steady stream of people from all walks of life transitioning in the corridors of the terminal. For me, there was a mystique and elegance that was unique on my voyages to the airport.

This mystique is far from relatable these days. In fact, the allure and exotic nature of travel have certainly eroded for many over the past four decades. Like most people I know, we worry about timing to the airport because of traffic on the road, delays at the security checks, lack of adequate places to stage at the gate, and so on. Added to this list include the fear of getting sick from your coughing neighbor, dirty rest areas, filtered air, the constant reminders about access to clean water, and the inevitable struggle that altitude travel can present while attempting to stay healthy on any trip.

The CDC, too, warns us of a list of conditions that could be harmful for humans as we travel. If you read their recommendations, you may never wish to step out of your house at all!

As an active business and leisure traveler for over 40 years, I can certainly share a few horror stories of my own about life on the road. But the reality is, travel is an integral part of the modern world. To avoid travel (specifically air travel) will deny you the opportunities to enjoy potential new adventures and the obvious benefits that leaving the comforts of home can offer.

Each of my less-than-optimal travel experiences has made me somewhat of an expert on how to make travel a healthier and more comfortable experience.

For instance, in advance of any air travel, I am particularly cognizant of my diet, sleep and exercise. Staying hydrated, getting exercise and rest will go a long way to keep you protected when you are in crowded public places. Secondly, I always arm myself with some modern technology to help keep my circulation and health at an optimum level regardless of my ability to move in confined places.

In an effort to impart some of my sagely travel advice to you, the following list includes my personal travel must-haves that I never hit the road without. The best part, they are easily portable and TSA approved to minimize any hassle:

1. Compression socks

Compression socks not only increase circulation, they potentially help stave off DVT or deep vein thrombosis. This condition can be life altering; in some cases, even fatal. Compression socks and other devices can help a person with this condition or prevent it after surgery if they have poor circulation.

2. Neck Pillows

Neck pillows can provide a whole lot of benefit, specifically you have your own clean pillow when you rest on a plane. It’ll help increase your chances of sleep, which (as we all know) can be one of the most challenging aspects of travel, especially internationally.

3. Personal Ear buds and Anti-bacterial Wipes

Personal use ear buds and anti- Bacterial wipes are both recommended as an easy way to take control of your space within an airplane seat, while also keeping sickness at bay.

4. Portable PEMF devices (similar to those that the astronaut’s use)

PEMF is a widely researched therapy that is regularly deployed by our friends at NASA. NASA astronauts have optimized PEMF devices for many years simply due to the clinical efficacy of the many positive effects this technology creates in and around the human body. NASA has determined, through decades of study, that the ravages of air and space travel decrease the body’s ability to maintain proper circulation, bone density and overall wellness. In combating this physical limit, NASA uses PEMF to not only protect but to strength an astronaut during their ventures. One consumer-friendly PEMF device that is FDA-registered and TSA approved is called Oska Pulse (www.oskawellness.com).

Next time you hit the road, arm yourself with these tools and advice to ensure you are maximizing your comfort and health while you travel. Take it from me: it’ll make all the difference.

 

READ MORE ABOUT OSKA HERE

Read More
aa06b1b7472a532a31d8a5fc93421707.jpg

Stryker Presents First K9s For Warriors Donation At The Honda Classic

Posted On February 21, 2017 By OrthoSpineNews In Sports Medicine, Top Stories /  

MAHWAH, N.J., Feb. 21, 2017 /PRNewswire/ — Stryker Orthopaedics is pleased to announce its second PGA TOUR stop of 2017 with a first-ever appearance at The Honda Classic in Palm Beach Gardens, FL. Throughout the tournament, Stryker will further its commitment to joint health and to the nation’s military through a series of engaging activities for fans and tournament goers. On Thursday, Stryker will host a special K9s For Warriors ceremony, presenting one military hero with a service dog – Stryker’s first official canine sponsorship donation of the year.

As an extension of a successful relationship that began last year, in 2017 Stryker will continue to give a new leash on life to military heroes by sponsoring service canines and empowering veterans to return to civilian life with dignity and independence. Tournament goers can also show their support to veterans by purchasing the same hat that PGA TOUR professionals and longtime brand ambassadors, Fred Funk and Hal Sutton wear on TOUR at the newly renovated Mobility Zone – Stryker’s premiere “joint health” destination. With each hat purchase, Stryker will make a donation to the K9s For Warriors organization.

“This donation is just one of many ways in which we are honored to show our appreciation towards our nation’s veterans,” said Bill Huffnagle, President, Stryker’s Joint Replacement Division. “Stryker is proud to support our military and continue our mission to educate people about joint health and mobility in local communities across the nation.”

In addition to offering hats for sale to benefit K9s For Warriors, fans visiting The Mobility Zone will be able to learn about hip and knee pain and treatment options, as well as participate in fun, health inspired activities. Inside The Mobility Zone, fans can participate in the 2017 Stryker Challenge – a hands-on experience featuring Art H. Ritis, a life-size model that aims to provide tournament goers a basic understanding of joint replacement surgery and Stryker’s products. In addition, fans who stop by The Mobility Zone will be able to enter for a chance to win a trip for two to Atlanta, GA for the TOUR Championship® and walk inside the ropes as an honorary observer – a true VIP experience.1,2

Finally, to further demonstrate its commitment to motivating fans to stay active, Stryker will host the Health Walk at The Honda Classic. The Health Walk highlights joint health facts and tips along the course to educate fans as they follow their favorite golfers.

For a full list of tournaments stops, additional information on the Stryker Challenge as well as K9s For Warriors involvement, please visit: www.StrykerChallenge.com.

  1. Healthcare Professionals (HCPs) are not eligible to enter the Stryker Challenge Sweepstakes or participate in the any of these promotions. HCPs are defined as those individuals or entities involved in the provision of health care services and/or items to patients, which purchase, lease, recommend, use, arrange for the purchase or lease of, or prescribe Stryker’s products.
  2. No purchase necessary to enter or win Sweepstakes.  Void where prohibited by law.  For official rules visit StrykerChallenge.com.  Open to legal residents of the US & US Territories, 21+ as of date of entry.  Sweepstakes begins at 12:01 am ET on 1/11/17 and ends at 11:59 pm ET on 8/27/17.  Sponsored by Stryker.

About Stryker
Stryker is one of the world’s leading medical technology companies and, together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. Stryker is active in over 100 countries around the world.

About PGA TOUR
The PGA TOUR is the world’s premier membership organization for touring professional golfers, co-sanctioning more than 130 tournaments on the PGA TOUR, PGA TOUR Champions, Web.com Tour, PGA TOUR Latinoamérica, Mackenzie Tour-PGA TOUR Canada and PGA TOUR China.

Read More
BOARD-OF-DIRECTORS.jpg

Breg Appoints Longtime Health Care Leader to Board of Directors

Posted On February 14, 2017 By OrthoSpineNews In Sports Medicine /  

CARLSBAD, Calif., Feb. 13, 2017 /PRNewswire/ — Breg, Inc., a premier provider of integrated solutions that help improve the quality and lower the cost of the orthopedic episode, today announced the appointment of Ken Paulus to the company’s board of directors.  Mr. Paulus has more than 25 years of experience leading integrated delivery systems and physician networks.

Mr. Paulus previously served as president and chief executive officer of Allina Health, one of the nation’s largest integrated delivery systems.  Under his leadership, Allina Health grew to encompass more than 100 hospitals and ambulatory care clinics and received the Davies award for offering one of the industry’s most integrated and advanced information systems.  Prior to Allina, Mr. Paulus was president and CEO of Atrius Health System, the largest integrated physician group in New England, and a research affiliate of Harvard Medical School.  He also served as chief operating officer of Partners Community HealthCare, a major teaching and research affiliate of Harvard Medical School.

“Ken brings a unique perspective and years of experience in health care delivery to our board,” said Brad Lee, president and CEO, Breg. “He will contribute greatly to our goal of extending Breg’s leadership in the orthopedic industry, particularly in providing comprehensive solutions to patients and caregivers that enhance and improve the quality of the entire orthopedic episode.”

In addition to Breg, Mr. Paulus serves on the boards of directors of Health Grades, Team Health and Cogentix Medical.  He earned a bachelor’s degree in biology from Augustana College and a master’s of health care administration from the University of Minnesota.

About Breg, Inc.
Breg provides remarkably easy products, services, technology and consulting to improve the quality and lower the cost of the orthopedic episode, from conservative treatment to pre- and post-surgery. The second largest U.S. provider of orthopedic bracing, Breg is a partner to 6,000 orthopedic surgeons and 90 percent of Integrated Delivery Networks who provide sports medicine and rehabilitation products to one million patients annually. Breg’s interconnected programs and total solutions are designed to fit specific customer needs, giving time back to providers and patients alike to focus on what’s most important. Breg is a company of Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry. Founded in 1989, Breg is based in Carlsbad, CA. Visit www.breg.com.

SOURCE Breg, Inc.

Related Links

http://www.breg.com

Read More
StamfordHospital.jpg

Hospital For Special Surgery Collaborates With Stamford Health

Posted On February 10, 2017 By OrthoSpineNews In Extremities, Sports Medicine /  

STAMFORD, Conn. — Stamford Health and Hospital for Special Surgery (HSS) formally announced a collaboration to create the premier center for advanced orthopedic care serving Connecticut and New England.

HSS Orthopedics at Stamford Health will provide a level of inpatient and ambulatory care unrivaled in the region. Under the collaboration, Stamford Health will adopt HSS best practices across the entire orthopedic service line, and surgeons from HSS in New York City will be providing care through HSS Orthopedics at Stamford Hospital.

HSS is the world’s leading academic medical center focused on musculoskeletal health and has been ranked the No. 1 hospital for orthopedics in the U.S. for the past seven consecutive years by U.S News & World Report. HSS leads the field of orthopedics nationwide for successful outcomes, and lowest infection, complication and revision rates.

“We believe this strategic and innovative relationship with HSS will elevate our institution to the forefront of musculoskeletal services and further differentiate us from others in the region,” said Brian G. Grissler, President and CEO, Stamford Health. “Through this collaboration, we will create a new Department of Orthopedic Surgery that integrates best practices and expands our capabilities.”

“We are drawing upon the very best skills, talent and resources of HSS and Stamford Health in what is truly a transformational collaboration between our two organizations,” said Louis A. Shapiro, President and CEO, Hospital for Special Surgery. “This revolutionary alliance will bring world-class orthopedic care closer to home for thousands of Connecticut residents, so fewer will need to leave the state for such care.”

HSS Orthopedics at Stamford Health will be available on a dedicated fifth floor of the acclaimed new Stamford Hospital building late this year, and later this month at Tully Health Center.

“Stamford Health has been providing tertiary care to the residents of Fairfield County for more than 120 years,” Grissler said. “Building upon our existing foundation of service, Magnet status nursing and a brand new hospital, this collaboration will take their orthopedic services to the next level.”

HSS has provided pre-, post- and non-surgical care in Connecticut since 2001. The 20,000 square foot HSS Outpatient Center at Chelsea Piers Connecticut in Stamford will continue to provide those services, as will the neighboring HSS-Stamford Health Sports Rehab facility.

Read More
AAEAAQAAAAAAAAIiAAAAJGI3ODJjOTU4LTAwMDEtNDIyMC1iYTZiLThjNTlhMTY2NTZkOA-1.jpg

Arlington Orthopedic Associates, P.A. Performs First Meniscus Replacements in Texas with NUsurface® Meniscus Implant

Posted On February 9, 2017 By OrthoSpineNews In Sports Medicine /  

February 09, 2017

ARLINGTON, Texas–(BUSINESS WIRE)–Arlington Orthopedic Associates, P.A., one of the largest orthopedic practices in North Texas, and Active Implants, a company that develops orthopedic implant solutions, today announced that the first meniscus replacement procedures in Texas were successfully performed by Dr. Joseph Berman. Arlington Orthopedic Associates and its affiliate Baylor Orthopedic and Spine Hospital is the only center in the state – and one of just 10 sites nationwide – enrolling patients with persistent knee pain caused by injured or deteriorating meniscus cartilage in the SUN trial, which is designed to assess the safety and effectiveness of the NUsurface® Meniscus Implant (pronounced “new surface”) in restoring function similar to that of a natural, healthy meniscus.

One of the recipients was 44-year-old Denton resident Jon Foerster, who tore his meniscus five years ago while running the bases during a kickball game. Although he underwent a partial meniscectomy to treat the tear, he continued to suffer from aching pain while running or playing sports. His pain persisted to the point where he had to discontinue all high impact activities, including the sports he loved like soccer, kickball and skiing. Gradually, Foerster found that even with a high pain tolerance level, his knee pain became so severe he found it taxing to walk more than one mile and also had trouble sleeping at night.

The meniscus is a tissue pad between the thigh and shin bones. Once damaged, the meniscus has a very limited ability to heal. Over 1 million partial meniscectomies to remove or repair a torn meniscus are performed in the U.S. every year, about the same as the total number of hip and knee replacement surgeries combined. However, many patients still experience persistent knee pain following meniscus surgery.

“There aren’t many options for patients like Jon who experience persistent knee pain following meniscus surgery,” said Dr. Joseph Berman, orthopedic surgeon at the Joint Preservation Center of Arlington Orthopedic Associates. “The NUsurface implant offers the hope of alleviating pain and swelling in these patients with chronic problems. We may well be able to help delay or even avoid knee replacement surgery, allowing these patients to get back to activities they love.”

Foerster received the NUsurface Meniscus Implant on January 16 through a small incision in his knee and he is now undergoing a six-week rehabilitation program. Foerster is looking forward to getting back into boating, skiing and spending time with his family once he recovers from the NUsurface surgery.

“Receiving the NUsurface Meniscus Implant will help me to look forward to my future with my kids,” Foerster said. “I want keep up as they continue to grow and be able to play sports with them.”

The NUsurface Meniscus Implant has been used in Europe under CE Mark since 2008 and Israel since 2011.

About the Clinical Trial

The SUN study (Safety Using NUsurface®) will enroll approximately 120 patients as part of regulatory process to gain approval from FDA to sell the device in the U.S. All patients who meet study requirements and agree to enter the trial are offered the NUsurface Meniscus Implant as treatment. Treatment with NUsurface in the SUN trial is eligible for coverage by Medicare and some private insurance companies. To be eligible for the study, participants must be between the ages of 30 and 75 and have pain after medial meniscus surgery that was performed at least six months ago. To learn more about the SUN study, please visit http://sun-trial.com or call (844) 680-8951.

About the NUsurface® Meniscus Implant

The NUsurface® Meniscus Implant is an investigational treatment for patients with persistent knee pain following medial meniscus surgery. It is made from medical grade plastic and, as a result of its unique materials, composite structure and design, does not require fixation to bone or soft tissues. The NUsurface Meniscus Implant mimics the function of the natural meniscus and redistributes loads transmitted across the knee joint. Clinical trials are underway in the U.S., Europe and Israel to verify the safety and effectiveness of the NUsurface Meniscus Implant.

About Arlington Orthopedic Associates

Arlington Orthopedic Associates, P.A. is one of the largest orthopedic practices in North Texas providing orthopedic care to the Dallas and Fort Worth area. AOA has four offices in Arlington, Mansfield, Irving and Odessa. We specialize in sports medicine, orthopedic surgery, spine care, joint replacement and reconstruction, and the care of bones, ligaments, tendons, muscles and nerves in adults and children. Additional services include physical medicine and rehabilitation, as well as state-of-the-art imaging and diagnostics services, all at four suitable locations. For more information, visit www.arlingtonortho.com or call 817-375-5200.

About Active Implants

Active Implants, LLC develops orthopedic implant solutions that complement the natural biomechanics of the musculoskeletal system, allowing patients to maintain or return to an active lifestyle. Active Implants is privately held with headquarters in Memphis, Tennessee. European offices are in Driebergen, The Netherlands, with R&D facilities in Netanya, Israel. For more information, visit www.activeimplants.com.

CAUTION Investigational device. Limited by United States law to investigational use.

Contacts

Merryman Communications for Active Implants
Joni Ramirez, 323-532-0746
joni@merrymancommunications.com
or
Arlington Orthopedic Associates, P.A.
Stacie Duncan Berlin, 817-375-5355
sberlin@arlingtonortho.com

Read More
scp_procedure-fill.jpg

Zimmer Biomet Announces the International Release of the Innovative Subchondroplasty® Procedure

Posted On February 8, 2017 By OrthoSpineNews In Extremities, Sports Medicine /  

WARSAW, Ind., Feb. 7, 2017 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, announced today the international release of the Subchondroplasty® (SCP®) Procedure.  The Company received CE Mark approval for the commercialization of its SCP Procedure to facilitate distribution in the European Union (EU) and other countries that recognize the CE Mark.  Zimmer Biomet also received approval for distribution in Canada, Singapore, Malaysia and Hong Kong.

The SCP Procedure is a minimally invasive outpatient intervention that addresses the defects associated with subchondral bone marrow lesions (BMLs). Diagnosed using an MRI and physical exam, BMLs are associated with stress fractures or micro-fractures of the bone adjacent to the joint. Left untreated, these defects may lead to cartilage degeneration, limited function, pain and a greater risk for joint deterioration.

SCP is performed to repair chronic BMLs by filling them with AccuFill® Bone Substitute Material, a porous injectable calcium phosphate (CaP). The bone substitute is then slowly resorbed and replaced with healthy bone, repairing the bone defect.

The procedure is usually performed along with arthroscopy for visualization and treatment of findings inside the joint. In some cases, an open or mini-open procedure is necessary for access to the defect.

“The Subchondroplasty procedure addresses a previously unmet need in my practice for patients with chronic and painful bone marrow lesions,” said Dr. Christopher Baker, orthopaedic surgeon at Florida Orthopedic Institute in Tampa, Fla. “These patients no longer benefit from conservative treatment, yet are not ready for total joint replacement surgery.”

Initially used only in bone defects of the knee, the SCP Procedure has been successfully performed in other areas including bones of the foot, ankle and hip. Zimmer Biomet now owns 36 patents and eight trademarks in this area, with numerous others still pending.

“The international release of the Subchondroplasty Procedure is a major milestone for our company and for patients with chronic bone marrow lesions,” said David Nolan, Zimmer Biomet Group President, Biologics, Extremities, Sports Medicine, Surgical, Trauma, Foot and Ankle, Office Based Technologies and Zimmer Biomet Signature Solutions. “The procedure offers a tool that fills a gap in the patient treatment algorithm for the surgeon. We are eager to begin our international commercial launch.”

For more information on the SCP Procedure, please visit www.subchondroplasty.com.

About Zimmer Biomet

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; office based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.

We collaborate with healthcare professionals around the globe to advance the pace of innovation. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Together with healthcare professionals, we help millions of people live better lives.

We have operations in more than 25 countries around the world and sell products in more than 100 countries. For more information, visit www.zimmerbiomet.com or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.

Cautionary Statement Regarding Forward-Looking Statements

This news release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements include, but are not limited to, statements concerning Zimmer Biomet’s expectations, plans, prospects, and product and service offerings, including new product launches and potential clinical successes.  Such statements are based upon the current beliefs and expectations of management and are subject to significant risks and uncertainties that could cause actual outcomes and results to differ materially.  For a list and description of some of such risks and uncertainties, see our periodic reports filed with the SEC.  These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in Zimmer Biomet’s filings with the SEC.  We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports.  Accordingly, such forward-looking statements speak only as of the date made.  Readers of this news release are cautioned not to place undue reliance on these forward-looking statements, since, while management believes the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate.  This cautionary statement is applicable to all forward-looking statements contained in this news release.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/zimmer-biomet-announces-the-international-release-of-the-innovative-subchondroplasty-procedure-300403563.html

SOURCE Zimmer Biomet Holdings, Inc.

News Provided by Acquire Media

Read More
partners.jpg

Trice Medical, Inc. and Pacific Medical, Inc. announces multi-state distribution agreement.

Posted On February 3, 2017 By OrthoSpineNews In Extremities, Sports Medicine /  

2/2/2017

King of Prussia, PA., and Tracy, CA.. – reported today on the completion of a distribution agreement with Pacific Medical, Inc., a distributor of durable medical equipment in the United States who specializes in orthopedic, rehabilitation, surgery and sports medicine.

Pacific Medical will be responsible for the promotion and distribution of the mi-eye 2™, an in-office arthroscopic diagnostic tool, in Northern California, Northern Nevada and the Pacific Northwest including Oregon, Washington, Alaska, Idaho and Montana. The partnership with Pacific Medical puts the mi-eye 2 in the hands of 300 dedicated sales and service personnel. Pacific Medical has long been a pioneer of surgeon and physician training, including a 12-station state of the art wet bioskills lab, which includes a 300-seat auditorium that Trice Medical and PacMed will utilize to enhance surgeon education throughout the Pacific Northwest.

“Trice Medical is thrilled to have PacMed as our distribution partner for the mi-eye 2 in the Northwest. The PacMed team has a long history of educating Orthopedic Surgeons on new technology. They are focused on partnering with their customers to deliver value to physicians, payers and patients.” Said Mark Foster, Chief Commercialization Officer for Trice Medical. “The mi-eye 2 is designed to deliver INSTANT ANSWERS to those same stakeholders and we are looking forward to successfully expanding our reach into the Northwest.”

Paul Wiese, VP of Sales for Pacific Medical stated. “The mi-eye 2 will allow us to continue in our mission of providing innovative technologies and advanced modalities that help our surgeon partnerships in their pursuit of increasing the surgeon-patient experience. Surgeons will be able to confirm their clinical diagnosis same day and eliminate the potential need for patients to take addition time away from work or leisure, to get the answers to their injuries.  The mi-eye 2 technology allows the physician to immediately plan the care of their patient, can take the guesswork out of MRI’s, and patients will now be intimately involved with their surgeons in the care of their injuries. We are very excited about our partnership with Trice Medical and the impact this technology will have on improving the quality of healthcare services provided by our physicians.”

About Trice Medical, Inc. 

Trice Medical was founded to fundamentally improve orthopedic diagnostics for the patient, physician, and payor by providing instant answers. Trice Medical has pioneered fully integrated camera-enabled technology, the mi-eye 2, that provides a clinical solution optimized for the physician’s office. Trice Medical’s mission is to provide more immediate and definitive patient care, eliminating the false reads associated with current indirect modalities and significantly reduce the overall cost to the healthcare system.

Trice Medical is a venture capital backed company; Safeguard Scientifics

(NYSE:SFE), BioStar Ventures and HealthQuest Capital are its major investors; smaller firms and angel investors have completed the rounds.

For more information, visit tricemedical.com or call 844.643.9300.

About Pacific Medical, Inc.

Pacific Medical, Inc. is a distributor of durable medical equipment, sports medicine medical devices, and orthotics; specializing in orthopaedic rehabilitation, arthroscopic surgery, and sports medicine.  Our corporate headquarters are in Tracy, California. Pacific Medical operates in seven western states, with a sales force of more than 100 highly skilled representatives. Incorporated in 1992, the Company now represents several industry leading manufacturers in the states of California, Nevada, Oregon, Washington, Montana, Alaska, and Idaho. This exponential growth has been very carefully planned and charted by an experienced management team.  Our success in the volatile healthcare industry can be directly attributed to the strong relationships forged with our customer base of orthopaedic surgeons, hospital administrators, physical therapists, and trainers.

 

https://www.pacmedical.com/

BACK

 

Read More